Abstract
The discovery of endogenous substances with opioid activity, the endorphins, in man and other species (Hughes, 1975; Pert et al.,1975; Simon, 1975) has stimulated recent investigations attempting to determine the role of these morphinelike substances in the brain. Thus far, two pentapeptides have been identified in the brain with potent opiate agonist activity. While recent studies and hypotheses have suggested a role for opioid peptides in mania, anxiety, psychosis, pain perception, motor behavior, and neuroendocrine regulation (Gold and Byck, 1978; Gold et al., 1977, 1979a; Kleber and Gold, 1978), little attention has been given to how these opioid peptides and receptors interact with other neurotransmitter systems to produce opiatelike effects and how this information might lead to a neural substrate for the signs, symptoms, and affects associated with opiate withdrawal and panic states in man (Gold and Pottash, 1980).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aghajanian, G. K., 1978, Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine, Nature (London) 276: 186.
Atweh, S. F., and Kuhar, M. J., 1977, Autoradiographic localization of opiate receptors in rat brain. II. The brain stem, Brain Res. 129: 1.
Bird, S. J., and Kuhar, M. J., 1977, Iontophoretic application of opiates to the locus coeruleus, Brain Res. 122: 523.
Bird, S. J., Atweh, S. F., and Kuhar, M. J., 1976, Microiontophoretic study of the effects of opiates on autoradiographically localized opiate receptors, in: Opiates and Endogenous Opioid Peptides ( H. W. Kosterlitz, ed.), pp. 199–204, Elsevier, Amsterdam.
Bunney, W. E., Jr., Goodwin, F. K., and Murphy, D. L., 1972, The “switch process” in manic-depressive illness. III. Theoretical implications, Arch. Gen. Psychiatry 27: 312.
Carroll, B. J., and Sharp, P. T., 1972, Monoamine mediation of the morphine-induced activation of mice, Br. J. Pharmacol. 46: 124.
Cedarbaum, J. M., and Aghajanian, G. K., 1976a, Characterization of catecholamine receptors on noradrenergic neurons of the locus coeruleus, Soc. Neurosci. Abstr. 2: 263.
Cedarbaum, J. M., and Aghajanian, G. K., 1976b, Noradrenergic neurons of the locus coeruleus: Inhibition by epinephrine and activation by the alpha-antagonist piperoxane, Brain Res. 112: 413.
Cedarbaum, J. M., and Aghajanian, G. K., 1977, Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization, Eur. J. Pharmacol. 44: 375.
Crawley, J. N., Laverty, R., and Roth, R. H., 1979, Clonidine reversal of increased nor-epinephrine metabolite levels during morphine withdrawal, Eur. J. Pharmacol. 57: 247.
Creese, I., Feinberg, A. P., and Snyder, S. H., 1976, Butyrophenone influences on the opiate receptor, Eur. J. Pharmacol. 36: 231.
Dahlström, A., and Fuxe, K., 1964, Evidence for the existence of monoamine containing neurons in the central nervous system. 1. Demonstration of monoamines in the cell bodies of brain stem neurons, Acta Physiol. Scand. Suppl. 232: 1.
DiChiara, G., Tagliamonte, A., Tagliamonte, P., and Gessa, G. L., 1972, Evidence that methadone blocks dopamine receptors in the brain, J. Neurochem. 19: 1953.
Eddy, N. B., and May, E. L., 1973, Origin and history of antagonists, in: Narcotic Antagonists (M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal, eds.), Advances in Biochemical Psychopharmacology pp. 9–11, Raven Press, New York.
Eidelberg, E., 1976, Possible action of opiates upon synapses, Prog. Neurobiol. 3: 81.
Eidelberg, E., and Espamer, R., 1975, Dopaminergic mechanisms of opiate actions in brain, J. Pharmacol. Exp. Ther. 192: 50.
EI-Sobky, A., Dostrovsky, J. O., and Wall, P. D., 1976, Lack of effect of naloxone on pain perception in humans, Nature (London) 263: 783.
Extein, I., Pickar, D., Gold, P. W., Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Ross, R. J., Rebard, R., Martin, D., and Goodwin, F. K., 1979, Methadone and morphine in depression, Annual Meeting of the American College of Neuropharmacology, San Juan, Puerto Rico.
Frankenhaeuser, M., 1975, Experimental approaches to the study of catecholamines and emotion, in: Emotions: Their Parameters and Measurement ( L. Levy, ed.), pp. 209–234, Raven Press, New York.
Frederickson, R. C., and Norris, F. H.,. 1976, Enkephalin-induced depression of single neurons in brain areas with opiate receptors—Antagonism by naloxone, Science 194: 440.
Gerner, R. H., Post, R. M., and Bunney, W. E., Jr., 1976, A dopaminergic mechanism in mania, Am. J. Psychiatry 133: 1177.
Gessa, G. L., and Tagliamonte, A., 1975, Effect of methadone and dextromoramide on dopamine metabolism: Comparison with haloperidol and amphetamine, Neuropharmacology 14: 913.
Gessa, G. L., Vargiu, L., Gibbio, G., and Tagliamonte, A., 1973, Effect of methadone on brain dopamine metabolism, in Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.),pp. 1011–1014, Pergamon Press, Elmsford, N.Y.
Gold, M. S., and Byck, R., 1978, Endorphins, lithium, and naloxone: Their relationship to pathological and drug-induced manic-euphoric states, in The International Challenge of Drug Abuse (R. C. Peterson, ed.), National Institute on Drug Abuse Research Monograph Series 19, pp. 192–209, DHEW, Washington, D.C.
Gold, M. S., and Kleber, H. D., 1979, A rationale for opiate withdrawal symptomatology, Drug Alcohol Depend. 4: 419.
Gold, M. S., and Pottash, A. L. C., 1980, The neurobiological implications of clonidine HC1, Ann. N.Y. Acad. Sci. 8: 191–202.
Gold, M. S., and Redmond, D. E., Jr., 1977, Pharmacological activation and inhibition of noradrenergic activity alter specific behaviors in nonhuman primates, Soc. Neurosci. Abstr. 3: 250.
Gold, M. S., Donabedian, R. K., Dillard, M., Slobetz, F. W., Riordan, C. E., and Kleber, H. D., 1977, Antipsychotic effect of opiate agonists, Lancet 2: 398.
Gold, M. S., Redmond, D. E., Jr., Donabedian, R. K., Goodwin, F. K., and Extein, I. L., 1978a, Increase in serum prolactin by exogenous and endogenous opiates: Evidence for antidopamine and antipsychotic effects, Am. J. Psychiatry 135: 1415.
Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1978b, Clonidine in opiate withdrawal, Lancet 1: 929.
Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1978c, Clonidine blocks acute opiate-withdrawal symptoms, Lancet 2: 599.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Kleber, H. D., and Redmond, D. E., Jr., 1979a, Rapid opiate detoxification: Clinical evidence of antidepressant and antipanic effects of opiates, Am. J. Psychiatry 136: 982.
Gold, M. S., Sweeney, D. R., Pottash, A. L. C., and Kleber, H. D., 1979b, Decreased serum prolactin in opiate withdrawal and dopaminergic hyperactivity, Am. J. Psychiatry 136: 849.
Gold, M. S., Byck, R., Sweeney, D. R., and Kleber, H. D., 1979c, Endorphin—locus coeruleus connection mediates opiate action and withdrawal, Biomedicine 30: 1.
Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1979d, Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal, Am. J. Psychiatry 136: 100.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., and Kleber, H. D., 1980a, Clonidine detoxification: A fourteen day protocol for rapid opiate withdrawal, in: Problems of Drug Dependence 1979 (S. Lewis and P. H. D. Harris, eds.), National Institute on Drug Abuse Research Monograph Series 27, p. 226, DHEW, Washington, D.C.
Gold, M. S., Pottash, A. L. C., Sweeney, D. R., and Kleber, H. D., 1980b, Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment, J. Am. Med. Assoc. 243: 343.
Gold, M. S., Pottash, A. L. C., Kleber, H. D., Extein, I., Augusthy, K. A., and Sweeney, D. R., 1981, Clonidine and lofexidine reverse opiate withdrawal, American Psychiatric Association Abstract, 156.
Gold, M. S., Pottash, A. L. C., Extein, I., and Kleber, H. D., 1980c, Clonidine and opiate withdrawal, Lancet 2: 1078.
Goldenberg, M., Snyder, C. H., and Aranow, H., Jr. 1947, New test for hypertension due to circulating epinephrine, J. Am. Med. Assoc. 135: 971.
Goldstein, A., 1976, Opioid peptides (endorphins) in pituitary and brain, Science 193: 1081.
Goldstein, A., and Hansteen, R. W., 1977, Evidence against involvement of endorphins in sexual arousal and orgasm in man, Arch. Gen. Psychiatry 34: 1179.
Goldstein, A., and Hilgard, E. R., 1975, Failure of the opiate antagonist naloxone to modify hypnotic analgesia, Proc. Natl. Acad. Sci. USA 72: 2041.
Goldstein, A., Pryor, G. T., Otis, L. S., and Larsen, F., 1976, On the role of endogenous opioid peptides: Failure of naloxone to influence shock escape threshold in the rat, Life Sci. 18: 599.
Greenberg, D. A., Prichard, D. C., and Snyder, S. H., 1976, Alphanoradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist states, Life Sci. 19: 69.
Grevert, P., and Goldstein, A., 1977, Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects, Proc. Natl. Acad. Sci. USA 74: 1291.
Herz, A., Blasig, J., and Papeschi, R., 1974, Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats, Psychopharmacologia 39: 121.
Holmberg, G., and Gershon, S., 1961, Autonomic and psychic effects of yohimbine hydrochloride, Psychopharmacologia 2: 93.
Holtzman, S. G., 1974, Behavioral effects of separate and combined administration of naloxone and d-amphetamine, J. Pharmacol. Exp. Ther. 189: 51.
Holtzman, S. G., 1976, Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat, Psychopharmacologia 46: 223.
Huang, Y. H., Redmond, D. E., Jr., Snyder, D. R., and Maas, J. W., 1975, In vivo location and destruction of the locus coeruleus in the Stumptail Macaque (Macaca arctoides), Brain Res. 100: 157.
Hughes, J., 1975, Isolation of an endogenous compound from brain with pharmacological properties similar to morphine, Brain Res. 88: 295.
Janowsky, D., Judd, L., Huey, L., Roitman, N., Parker, D., and Segal, D., 1978, Naloxone effects on manic symptoms and growth hormone levels, Lancet 2: 320.
Janssen, P. A., 1965, The evolution of the butyrophenones, haloperidol and trifluperidol from meperidine-like 4-phenylpiperidines, Int. Rev. Neurobiol. 8: 221.
Jones, B. E., Halaris, A. E., Mclhany, M., and Moore, R. Y., 1977, Ascending projections of the locus coeruleus in the rat: I and II, Brain Res. 127: 123.
Karkalas, Y., and Lal, H. S., 1973, A comparison of haloperidol with methadone in blocking heroin withdrawal symptoms, Int. Pharmacopsychiatry 8: 248.
Kleber, H. D., and Gold, M. S., 1978, Use of psychotropic drugs in treatment of methadone maintained narcotic addicts, Ann. N.Y. Acad. Sci. 311: 81.
Kline, N. S., Li, C. H., Lehmann, H. E., Lajtha, A., Laski, E., and Cooper, T., 1977, Beta-endorphin induced changes in schizophrenic and depressed patients, Arch. Gen. Psychiatry 34: 111.
Kokka, N., Garcia, J. F., and Elliott, H. W., 1973, Effects of acute and chronic administration of narcotic analgesics on growth hormone and corticotrophin (ACTH)secretion in rats, Prog. Brain Res. 39: 347.
Korf, J., Aghajanian, G. K., and Roth, R. H., 1973, Stimulation and destruction of the locus coeruleus: Opposite effects on 3-methoxy-4-hydroxyphenyl glycol sulfate levels in the rat cerebral cortex, Eur. J. Pharmacol. 21: 305.
Korf, J., Bunney, B. S., and Aghajanian, G. K., 1974, Noradrenergic neurons: Morphine inhibition of spontaneous activity, Eur. J. Pharmacol. 25: 165.
Kuhar, M. J., 1978, Opiate receptors: Some anatomical and physiological aspects, Ann. N. Y. Acad. Sci. 311: 35.
Lal, H., 1975, Narcotic dependence, narcotic action and dopamine receptors, Life Sci. 17: 483.
Levi, L., 1972, Stress and distress in response to psychosocial stimuli. Laboratory and real life studies on sympathoadrenomedullary and related reactions, Acta Med. Scand. Suppl. 528–535.
Loizou, L. A., 1969, Projections of the nucleus locus coeruleus in the albino rat, Brain Res. 15: 563.
Maas, J. W., and Landis, D. H., 1971, The metabolism of circulating norepinephrine by human subjects, J. Pharmacol. Exp. Ther. 177: 600.
Maas, J. W., Hattox, S. E., Landis, D. H., and Roth, R. H., 1976, The determination of a brain arteriovenous difference for 3-methoxy-4-hydroxyphenethylene glycol (MHPG), Brain Res. 118: 167.
Maas, J. W., Greene, N. M., Hattox, S. E., and Landis, D. H., 1979, Neurotransmitter metabolite production by human brain, in Catecholamines: Basic and Clinical Frontiers ( E. Usdin, I. J. Kopin, and J. Barchas, eds.), pp. 1878–1880, Pergamon Press, Elmsford, N.Y.
Mandell, A. J., and Knapp, S., 1975a, Current research in the indoleamine hypothesis of affective disorders, Commun. Psychopharmacol. 1: 587.
Mandell, A. J., and Knapp, S., 1975b, Neurobiological antagonism of cocaine by lithium, in Cocaine and Other Stimulants ( E. H. Ellinwood, Jr., and M. M. Kilbey, eds.), pp. 187–200, Plenum Press, New York.
Morrison, J. H., Molliver, M. E., and Grazanna, R., 1979, Noradrenergic innervation of cerebral cortex: Widespread effects of local cortical lesions, Science 205: 313.
Murphy, D. L., Goodwin, F. K., Brodie, H. K., and Bunney, W. E., Jr., 1973, L-Dopa, dopamine and hypomania, Am. J. Psychiatry 130: 79.
Paalzow, L., 1974, Analgesia produced by clonidine in mice and rats, J. Pharm. Pharmacol. 26: 361.
Pert, C. B., and Snyder, S. H., 1974, Opiate receptor binding of agonists and antagonists affected differentially by sodium, Mol. Pharmacol. 10: 868.
Pert, C. B., Kuhar, M. J., and Snyder, S. H., 1975, Autoradiographic localization of the opiate receptor in rat brain, Life Sci. 16: 1849.
Puri, S. K., and Lal, H., 1974, Tolerance to the behavioral and neurochemical effects of haloperidol and morphine in rats chronically treated with morphine or haloperidol, Naunyn-Schmiedebergs Arch. Pharmacol. 282: 155.
Redmond, D. E., Jr., Huang, Y. H., and Gold, M. S., 1977, Anxiety: The locus coeruleus connection, Soc. Neurosci. Abstr. 3: 258.
Redmond, D. E., Jr., Huang, Y. H., and Gold, M. S., 1978, Evidence for the involvement of a brain norepinephrine (NE) system in anxiety, Proceedings 4th International Catecholamine Symposium, Pacific Grove, Calif.
Redmond, D. E., Jr., Roth, R. H., Hattox, S. E., Stogin, J. M., and Baulu, J., 1979, 3Methoxy-4-hydroxyphenethylene glycol (MHPG) in monkey brain, CSF, and plasma during naloxone precipitated morphine abstinence, Soc. Neurosci. Abstr. 5: 1160.
Rivier, C., Vale, W., Ling, N., Brown, M., and Guillemin, R., 1977, Stimulation in vivo of the secretion of prolactin and growth hormone by 3-endorphin, Endocrinology 100: 238.
Roberts, D. C., Mason, S. T., and Fibiger, H. C., 1978, 6-OHDA lesions to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy, Eur. J. Pharmacol. 52: 209.
Sakai, K., Touret, M., Salvert, D., Leger, L., and Jouvet, M., 1977, Afferent projections to the cat locus coeruleus as visualized by the horseradish peroxidase technique, Brain Res. 119: 21.
Schildkraut, J. J. 1965, The catecholamine hypothesis of affective disorders: A review of supporting evidence, Am. J. Psychiatry 122: 509.
Schmitt, H., Schmitt, Mme. H., and Fenard, S., 1971, Evidence for an alpha-sympathomimetic component in the effects of Catapresan on vasomotor centres: Antagonism by piperoxane, Eur. J. Pharmacol. 14: 98.
Simon, E. J., 1975, Opiate receptor binding with 3H-etorphine, Neurosci. Res. Program Bull. 13: 43.
Snyder, S. H., and Simantov, R., 1977, The opiate receptor and opiate peptides, J. Neurochem. 28: 13.
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., and Greenberg, D., 1974, Drugs, neurotransmitters, and schizophrenia, Science 184: 1243.
Soifer, A., 1954, Reginine and benodaine in the diagnosis of pheochromocytoma, Med. Clin. North Am. 38: 375.
Spitzer, R. L., Endicott, J., and Robins, E., 1978, Research diagnostic criteria: Rationale and reliability, Arch. Gen. Psychiatry 35: 773.
Starke, K., 1977, Regulation of noradrenaline release by presynaptic receptor systems, Rev. Physiol. Biochem. Pharmacol. 77: 1.
Strombom, U., 1975, On the functional role of pre-and postsynaptic catecholamine receptors in brain, Acta Physiol. Scand. Suppl. 431: 1.
Svensson, T. H., Bunney, B. S., and Aghajanian, G. K., 1975, Inhibition of both noradrenergic and serotonergic neurons in brain by the alpha-adrenergic antagonist clonidine, Brain Res. 92: 291.
Sweeney, D. R., Gold, M. S., Pottash, A. L. C., and Davies, R. K., 1980a, Neuro-biological theories, in: The Handbook of Stress and Anxiety: Current Knowledge, Theory and Treatment ( I. L. Kutash and L. B. Schlesinger, eds.), pp. 112–122, Jossey—Bass, San Francisco.
Sweeney, D. R., Gold, M. S., Ryan, N., and Pottash, A. L. C., 19806, Opiate withdrawal and panic anxiety, American Psychiatric Association Abstract, p. 123.
Sweeney, D. R., Gold, M. S., Pottash, A. L. C., and Martin, D. M., 1980c, Plasma levels of tricyclic antidepressants in panic disorder, Soc. Neurosci. Abstr. 1: 701.
Taube, H. D., Borowski, E., Endo, T., and Starke, K., 1976, Enkephalin: A potential modulator of noradrenaline release in rat brain, Eur. J. Pharmacol. 38: 377.
Tolis, G., Dent, R., and Guyda, H., 1978, Opiates, prolactin, and the dopamine receptor, J. Clin. Endocrinol. Metab. 47: 200.
Van Der Wende, C., and Spoerlein, M. T., 1973, Role of dopaminergic receptors in morphine analgesia and tolerance, Res. Commun. Chem. Pathol. Pharmacol. 5: 35.
von Graffenried, B. V., del Pozo, E., Roubicek, J., Krebs, E., Poldinger, W., Burmeister, P., and Kerp, L., 1978, Effects of the synthetic enkephalin analogue FK 33–824 in man, Nature (London) 272: 729.
Young, W. S., III, Bird, S. J., and Kuhar, M. J., 1977, Iontophoresis of methionine-enkephalin in the locus coeruleus area, Brain Res. 129: 366.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Gold, M.S., Pottash, A.C., Extein, I., Goodwin, F.K., Redmond, D.E., Kleber, H.D. (1982). Endorphin Dysfunction in Panic Anxiety and Primary Affective Illness. In: Shah, N.S., Donald, A.G. (eds) Endorphins and Opiate Antagonists in Psychiatric Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1119-5_21
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1119-5_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1121-8
Online ISBN: 978-1-4684-1119-5
eBook Packages: Springer Book Archive